IOL CHEMICALS & PHARM. | DISHMAN PHARMA | IOL CHEMICALS & PHARM./ DISHMAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 30.0 | 43.9% | View Chart |
P/BV | x | 1.5 | 3.3 | 44.7% | View Chart |
Dividend Yield | % | 1.0 | 0.7 | 156.6% |
IOL CHEMICALS & PHARM. DISHMAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
DISHMAN PHARMA Mar-16 |
IOL CHEMICALS & PHARM./ DISHMAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 374 | 143.3% | |
Low | Rs | 272 | 129 | 211.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 197.0 | 191.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 21.2 | 111.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 34.7 | 90.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.0 | 0.8 | 124.4% | |
Book value per share (Unadj.) | Rs | 256.8 | 179.9 | 142.8% | |
Shares outstanding (eoy) | m | 58.71 | 80.70 | 72.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.3 | 83.8% | |
Avg P/E ratio | x | 17.1 | 11.9 | 143.7% | |
P/CF ratio (eoy) | x | 12.8 | 7.3 | 176.7% | |
Price / Book Value ratio | x | 1.6 | 1.4 | 112.6% | |
Dividend payout | % | 16.9 | 9.4 | 178.8% | |
Avg Mkt Cap | Rs m | 23,743 | 20,307 | 116.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 5,355 | 31.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 15,898 | 139.5% | |
Other income | Rs m | 256 | 265 | 96.5% | |
Total revenues | Rs m | 22,427 | 16,163 | 138.8% | |
Gross profit | Rs m | 2,257 | 4,103 | 55.0% | |
Depreciation | Rs m | 462 | 1,091 | 42.3% | |
Interest | Rs m | 165 | 944 | 17.4% | |
Profit before tax | Rs m | 1,887 | 2,334 | 80.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 624 | 79.4% | |
Profit after tax | Rs m | 1,391 | 1,710 | 81.4% | |
Gross profit margin | % | 10.2 | 25.8 | 39.4% | |
Effective tax rate | % | 26.2 | 26.7 | 98.2% | |
Net profit margin | % | 6.3 | 10.8 | 58.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 11,018 | 87.7% | |
Current liabilities | Rs m | 5,025 | 9,517 | 52.8% | |
Net working cap to sales | % | 20.9 | 9.4 | 221.7% | |
Current ratio | x | 1.9 | 1.2 | 166.2% | |
Inventory Days | Days | 43 | 57 | 75.9% | |
Debtors Days | Days | 8 | 3 | 237.8% | |
Net fixed assets | Rs m | 11,017 | 18,787 | 58.6% | |
Share capital | Rs m | 587 | 161 | 363.8% | |
"Free" reserves | Rs m | 14,490 | 14,354 | 100.9% | |
Net worth | Rs m | 15,077 | 14,516 | 103.9% | |
Long term debt | Rs m | 0 | 4,189 | 0.0% | |
Total assets | Rs m | 20,684 | 29,805 | 69.4% | |
Interest coverage | x | 12.5 | 3.5 | 358.8% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.5 | 201.0% | |
Return on assets | % | 7.5 | 8.9 | 84.5% | |
Return on equity | % | 9.2 | 11.8 | 78.3% | |
Return on capital | % | 13.6 | 17.5 | 77.6% | |
Exports to sales | % | 26.7 | 24.9 | 107.5% | |
Imports to sales | % | 0 | 3.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 3,956 | 149.9% | |
Imports (cif) | Rs m | NA | 594 | 0.0% | |
Fx inflow | Rs m | 5,930 | 4,952 | 119.8% | |
Fx outflow | Rs m | 6,052 | 697 | 868.6% | |
Net fx | Rs m | -122 | 4,255 | -2.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,786 | 43.9% | |
From Investments | Rs m | -1,200 | -1,529 | 78.5% | |
From Financial Activity | Rs m | -41 | -941 | 4.4% | |
Net Cashflow | Rs m | -18 | 317 | -5.8% |
Indian Promoters | % | 48.2 | 61.4 | 78.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 23.0 | 7.4% | |
FIIs | % | 1.4 | 12.0 | 11.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 38.6 | 134.2% | |
Shareholders | 130,003 | 52,291 | 248.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Dishman Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | 2.87% | -0.44% |
1-Month | -4.51% | -2.45% | 2.15% |
1-Year | -4.09% | 96.38% | 49.82% |
3-Year CAGR | -12.01% | 89.34% | 14.21% |
5-Year CAGR | 15.35% | 38.20% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Dishman Pharma share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Dishman Pharma.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Dishman Pharma.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.